adenosine diphosphate has been researched along with penicillamine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaudhuri, G; Ignarro, LJ; Runge, A; Varela, AF | 1 |
Longo, LD; Pearce, WJ | 1 |
Castagna, ML; Fioravanti, A; Frati, E; Giordano, N; Lalumera, M; Lolatte, V; Marcolongo, R; Morozzi, G | 1 |
Currie, MG; Mollace, V; Salvemini, D | 1 |
Doni, MG; Picunio, S; Simioni, M | 1 |
Kosaka, H; Yoneyama, H; Zhou, MS | 1 |
Magid, KS; Megson, IL; Shaw, CA; Sogo, N; Webb, DJ | 1 |
Duszyk, M; Jurasz, P; Mayers, I; Miranda, C; Radomski, MW; Sawicka, J; Sawicki, G | 1 |
Berkels, R; Englemann, U; Klaus, W; Klotz, T; Sticht, G | 1 |
Baughman, VL; Pelligrino, DA; Santizo, RA; Xu, HL | 1 |
Hellsten, Y; Jensen, L; Schjerling, P | 1 |
1 trial(s) available for adenosine diphosphate and penicillamine
Article | Year |
---|---|
Modulation of human platelet aggregation by the phosphodiesterase type 5 inhibitor sildenafil.
Topics: Adenosine Diphosphate; Adult; Humans; Male; Middle Aged; Nitric Oxide Donors; Penicillamine; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation; Purines; Sildenafil Citrate; Sulfones; Time Factors | 2001 |
10 other study(ies) available for adenosine diphosphate and penicillamine
Article | Year |
---|---|
Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults.
Topics: Adenosine Diphosphate; Blood Platelets; Epinephrine; Epoprostenol; Female; Fetal Blood; Humans; Nitric Oxide; Osmolar Concentration; Penicillamine; Platelet Aggregation; Pregnancy; S-Nitroso-N-Acetylpenicillamine | 1992 |
Developmental aspects of endothelial function.
Topics: Adenosine Diphosphate; Aging; Animals; Animals, Newborn; Calcimycin; Cerebral Arteries; Cerebrovascular Circulation; Cyclic GMP; Endothelium, Vascular; Fetus; Humans; Nitroglycerin; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Sheep; Vasoconstriction; Vasodilation | 1991 |
[Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
Topics: Adenosine Diphosphate; Adult; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Gold; Gold Sodium Thiomalate; Humans; Penicillamine; Platelet Aggregation; Time Factors | 1984 |
Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Aorta; Cattle; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Hemoglobins; Humans; Kinetics; Male; Methylene Blue; Models, Cardiovascular; Molsidomine; Nitric Oxide; Nitroglycerin; Nitroprusside; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Vasodilation; Vasodilator Agents; Verapamil | 1996 |
Platelet activation and modulation of the induction of nitric oxide synthase in the conscious rat.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Enzyme Induction; Heart Rate; Iloprost; Lipopolysaccharides; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Penicillamine; Platelet Activation; Platelet Count; Rats; Rats, Wistar; Thrombocytopenia | 1999 |
Potassium augments vascular relaxation mediated by nitric oxide in the carotid arteries of hypertensive Dahl rats.
Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic beta-Agonists; Animals; Carotid Arteries; Colforsin; Dietary Supplements; Enzyme Inhibitors; Hypertension; Isoproterenol; Male; Nitrates; Nitric Oxide; Nitrites; Nitroarginine; Nitroprusside; Penicillamine; Potassium, Dietary; Rats; Rats, Inbred Dahl; S-Nitroso-N-Acetylpenicillamine; Sodium Chloride; Sodium-Potassium-Exchanging ATPase; Vasodilation; Vasodilator Agents | 2000 |
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Collagen; Cyclic GMP; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; In Vitro Techniques; Kinetics; Models, Biological; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Nitroso Compounds; Oxadiazoles; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Quaternary Ammonium Compounds; Quinoxalines; S-Nitrosoglutathione | 2000 |
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Topics: Adenosine Diphosphate; Blood Platelets; Cell Communication; Enzyme Inhibitors; Epoprostenol; Fibrosarcoma; Gelatinases; Glutathione; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Penicillamine; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Thromboxane A2; Tumor Cells, Cultured | 2001 |
Nascent EDHF-mediated cerebral vasodilation in ovariectomized rats is not induced by eNOS dysfunction.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Biological Factors; Blood Pressure; Cerebrovascular Circulation; Enzyme Inhibitors; Estradiol; Female; Hypercapnia; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Ovariectomy; Penicillamine; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 2003 |
Regulation of VEGF and bFGF mRNA expression and other proliferative compounds in skeletal muscle cells.
Topics: Adenosine; Adenosine Diphosphate; Animals; Cell Proliferation; Cells, Cultured; Electric Stimulation; Endothelium, Vascular; Fibroblast Growth Factor 2; Gene Expression Regulation; Humans; Indomethacin; Male; Muscle Cells; Muscle Contraction; Muscle, Skeletal; Nitric Oxide; Nitroarginine; Penicillamine; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; RNA, Messenger; Vascular Endothelial Growth Factor A | 2004 |